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ABSTRACT
In male germ cells many mRNAs are sequestered by
proteins into translationally silent messenger ribo-
nucleoprotein (mRNP) particles. These masked paternal
mRNAs are stored and translated at specific times of
germ cell development. Little is known about the
mammalian testicular mRNA masking proteins bound
to non-polysomal mRNAs. In this report, the major
proteins binding to non-polysomal testicular mRNAs
were isolated and analyzed. The two predominant
proteins identified were: a Y-box protein (MSY2), the
mammalian homolog to the Xenopus oocyte masking
protein FRGY2/mRNP3+4, and a poly(A) binding protein.
A kinase activity was also found associated with these
non-polysomal RNAs. The kinase co-immunoprecip-
itates with MSY2 and phosphorylates MSY2 in vitro.
The MSY2 associated kinase is not casein kinase 2, the
kinase believed to phosphorylate mRNP3+4 in oocytes,
but a yet unidentified kinase. MSY2 was found to be
phosphorylated in vivo and MSY2 dephosphorylation
led to a decrease in its affinity to bind RNA as judged
by northwestern blotting. Therefore, testicular masked
mRNAs may be regulated by the phosphorylation state
of MSY2. Reconstitution experiments in which non-
polysomal mRNA-binding proteins are dissociated
from their RNAs and allowed to bind to exogenous
mRNAs suggest that MSY2 binds RNA in a sequence-
independent fashion. Furthermore, association of the
non-polysomal derived proteins to exogenous non-
specific mRNAs led to their translational repression
in vitro.
INTRODUCTION
Spermatogenesis is the process of cellular differentiation in which
a population of diploid progenitor cells in the testis terminally
differentiate into haploid spermatozoa (1). During mammalian
spermatogenesis, the genome is repackaged and transcriptionally
silenced as histones are replaced with transition proteins and
protamines. However, ongoing protein synthesis is required for
the extensive differentiation of germ cells into mature gametes.
The regulated translation of stored RNAs, therefore, plays a
prominent role in the later stages of male germ cell development.
A number of paternal mRNAs which are synthesized early in
spermiogenesis, e.g., the transition proteins 1 and 2 and the
protamines 1 and 2, are stored within the cytoplasm. These RNAs
are translationally silent and are present in the non-polysomal
messenger ribonucleoprotein (mRNP) fraction presumably in
protein–RNA complexes termed mRNP particles or masked
mRNAs (2,3). At an appropriate time in development, these
stored RNAs become translationally competent. Although proteins
such as testis/brain-RNA binding protein (TB-RBP) and protamine
binding protein (Prbp) are believed to modulate expression of
specific mRNAs encoding proteins such as protamines (4,5), the
identity and function of the major proteins in the paternal mRNP
masking complexes of mammals is poorly understood.
Much is known on RNA masking in gametes from investigations
in Xenopus oocytes. During oogenesis in the frog, an analogous
situation occurs as in spermatogenesis. A number of RNAs
synthesized early in oogenesis are sequestered by proteins to form
mRNP particles. During the latter stages of oogenesis, these
masked RNAs are temporally activated to ensure terminal
differentiation of the oocyte into the mature egg.
Proteins associated with masked maternal mRNAs have been
identified in mature Xenopus oocytes. Two of these proteins were
found to be members of a family of Y-box transcription factors
named FRGY2 (mRNP4) and mRNP3 (6–10). A role for
mRNP3+4 in masking mRNA is suggested from several lines of
evidence. Reconstitution of mRNP3+4 with mRNA in vitro
represses translation (11,12) and expression of mRNP3+4 in
somatic cells leads to an increase in mRNA accumulation from
promoters carrying the Y-box consensus sequence and to
translational silencing of that RNA (13). It has also been
demonstrated that overexpression of mRNP3+4 in Xenopus
oocytes facilitates the silencing of RNA synthesized in vivo (14).
Antibodies recognizing the mRNP3+4 family of proteins relieve
the inhibition of translation when introduced into Xenopus
oocytes (15,16).
In Xenopus oocytes, the Y-box proteins are phosphorylated
leading to an increased affinity for RNA (12,17–20). Moreover,
phosphorylation of mRNP3+4 inhibits translation of its bound
RNA both in vitro and in vivo (12,15,21). It has been suggested
that phosphorylation of the Y-box proteins is important in the
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formation and disassembly of the mRNP particles (8,12,15,17).
The kinase believed responsible for the phosphorylation of
mRNP3+4 is casein kinase 2 (CK2) (15,18).
In Xenopus oocytes, other proteins including nucleolin (21),
nucleoplasmin (22) and Xp54 helicase (23) have also been found
associated with the mRNP fraction. Xp54 helicase has been
suggested to play a role in the unwinding of RNA secondary
structure leading to the initiation of translation (23), whereas
nucleoplasmin association has been shown to partially relieve the
translational repression of histone H4, an mRNA known to be
masked (22).
Y-box proteins have also been identified in mammalian testes
(24–27). From immunocytochemical studies, the mammalian
homologs are found to be abundant in the cytoplasm of meiotic
and post-meiotic male mouse germ cells, cell types containing
most of the paternal stored mRNAs (26). The Y-box proteins also
function in nuclear extracts where they can activate protamine 2
transcription in in vitro assays (28). Recent cloning and sequencing
of mouse testicular Y-box proteins has demonstrated the existence
of two spliced variants, MSY2 and MSY2a, the mammalian germ
cell homologs of FRGY2/mRNP3+4 (27). MSY1, a homolog of the
somatic Xenopus Y-box masking protein FRGY1, has also been
characterized (25).
In this study, we identify two major proteins, MSY2 and PABP,
and a kinase activity associated with mouse non-polysomal
mRNAs. Evidence is provided that binding and subsequent
translational repression by MSY2 is independent of RNA
sequence. The associated kinase phosphorylates MSY2 in vitro
and thereby likely influences its affinity to RNA. This testicular
mRNP associated kinase appears to differ from CK2, the kinase
found associated with the mRNP particles of Xenopus oocytes
(15,18).
MATERIALS AND METHODS
mRNP particle isolation from mouse testis
Decapsulated adult CD1 mouse testes were disrupted in 1×
gradient buffer (0.2 M KCl, 2 mM MgCl2, 20 mM Tris–HCl,
pH 7.4, 0.5% NP-40, 1 mM PMSF, 1 mg/l leupeptin, 1 mg/l
aprotinin, 1 mg/l pepstatin, 100 mM NaFl and 100 U/ml RNAsin)
using a glass–teflon homogenizer. After the homogenate was
spun at 10 000 g for 10 min at 4C to remove nuclei and cellular
debris, 250 µl (1.2 mg of protein/ml) of the clarified post-nuclear
supernatant was layered over a 4.75 ml 20–60% Nycodenz
gradient (Accurate Chemical and Scientific Corp.) and centrifuged
at 150 000 g for 20 h in a SW50 rotor (Beckman). The gradient
was divided into 18 fractions which were then further divided for
protein assays and northern and western blot analyses (described
below). The protein content of each fraction was assayed using
the Bradford protein assay (BioRad). For purification of mRNA
binding proteins, fractions sedimenting as mRNPs in Nycodenz
gradients (see Results) were pooled and oligo(dT) selected using
the PolyATtract mRNA isolation system (Promega). Briefly, total
mRNPs were annealed to biotinylated oligo(dT) in a 1× gradient
buffer, duplexes were collected on Streptavidin-coupled para-
magnetic beads, washed three times in 1× gradient buffer, and
once in 0.1× SSC. After elution in ddH2O, the eluent contained
an enriched population of mRNA–protein complexes. Proteins
were detected by silver staining using the Diachii silver stain kit
as described by the manufacturer.
Western blotting and immunoprecipitations
Western blotting was performed as described by Murray et al. (8).
Proteins were separated on an SDS–polyacrylamide gel and
electroblotted onto nitrocellulose. The nitrocellulose filters were
blocked with 1× TBS (20 mM Tris, 50 mM NaCl, pH 7.4)–5%
milk for 1 h and incubated with guinea pig anti-mRNP3+4
antibody at a 1/1000 dilution overnight at 4C. The blots were
then washed in 1× TBS, three times for 20 min. Antigen–antibody
complexes were detected using a chemiluminescence system
(Amersham International). For immunoprecipitations, the
mRNA–protein complexes were suspended in RIPA buffer [50 mM
Tris–HCl pH 7.5, 150 mM NaCl, 0.1% SDS, 1% NP-40, 0.5%
deoxycholate (DOC)] and pre-cleared by incubation with IgG
Sepharose beads (4C for 1 h). The supernatants were then
incubated for 12 h at 4C with anti-mRNP3+4 IgG Sepharose beads.
The precipitated complexes were washed five times in RIPA buffer
and resuspended in gel loading buffer (0.1 M DTT, 2% SDS,
0.625 M Tris, pH 6.8, 20% glycerol, bromophenol blue). After
boiling, the samples were electrophoresed through a 10% SDS–
polyacrylamide gel and the products visualized by autoradiography.
Northern blotting 
Samples fractionated on a 20–60% Nycodenz gradient were
phenol–chloroform extracted twice, ethanol precipitated and
resuspended in RNA loading buffer for electrophoresis through
1.5% agarose formaldehyde gels. The RNAs were transferred to
nylon membranes and hybridizations were performed overnight
at 65C in hybridization buffer with randomly primed 32P-labeled
cDNAs. The filters were washed four times in 0.5× SSC–5% SDS
for 20 min at 65C, dried, and exposed to autoradiographic film.
Reconstitution of mRNA–protein complexes and their ‘in
vitro’ translation
Dissociation/reconstitution experiments were performed using a
modification of the procedure of Pullman and Martin (29).
Briefly, protein was dissociated from purified oligo(dT) selected
mRNPs (4 µg of protein) with 0.5% DOC and RNA was digested
with micrococcal nuclease (300 µg/ml) in 1 mM CaCl2 at 23C
for 20 min. The digestion was stopped by the addition of 10 mM
EGTA. Reconstitution of the dissociated proteins with either
luciferase RNA or brome mosaic virus RNA (1 µg) was achieved
by the addition of 0.5% Triton X-100. Oligo(dT) selected
mRNPs, dissociated mRNPs incubated with 0.5% Triton X-100
and reconstituted mRNP particles were analyzed on a 20–60%
Nycodenz gradient. Reconstituted mRNP particles were translated
in a rabbit reticulocyte in vitro translation system in the presence
of [35S]methionine using the protocol of the manufacturer
(Promega). As a control, luciferase RNA was incubated in a
mixture of DOC, micrococcal nuclease, EDTA and Triton X-100
at concentrations indicated above prior to in vitro translation.
‘In vivo’ labeling of testicular proteins
Decapsulated mouse testes were digested with 500 µg/ml
collagenase–dispase (20 min, 32C), washed twice, and then
preincubated for 2 h at 32C in phosphate-free RPMI (Gibco). The
cells were incubated for an additional 4 h with [32P]orthophosphate
(250 µCi/ml), washed twice with RPMI, and resuspended in
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Assay of kinase activity
Approximately 0.1 µg of oligo(dT) selected mRNP particles were
incubated for 30 min at 30C in Kinase Buffer (KB: 100 mM
Tris–HCl pH 7.4, 10 mM MgCl2, 200 mM NaCl) in the presence
of [γ-32P]ATP (2 µCi) and 0.1 mM ATP. Inhibitors, activators
and/or substrates were added to the kinase reactions at the
concentrations indicated in Results.
Kinase assay of the mRNP complex of MSY2 and its
associated proteins
Isolated mRNPs were digested with RNases A and T1 for 30 min
at 37C, suspended in Immunoabsorption Buffer (IB: 20 mM
Tris–HCl pH 7.6, 150 mM KCl, 2 mM MgCl2, 2 mM DTT, 1%
Triton X-100, 1 mM PMSF, 1 mg/l leupeptin, 1 mg/l aprotinin,
1 mg/l pepstatin), and precleared by incubation with IgG
Sepharose beads (4C, 1 h). The supernatants were then
incubated for 12 h at 4C with anti-mRNP3+4 IgG Sepharose
beads. The immune complexes were washed five times with IB,
twice with KB, and in vitro kinase assays were performed as
described above.
Northwestern blot analysis 
Northwestern blotting was performed essentially as described by
Houman et al. (30). mRNPs were incubated at 37C for 30 min
with or without calf intestinal phosphatase (CIP; 25 U/ml)
(Boehringer Mannheim). After separation on a 10% SDS–poly-
acrylamide gel, the mRNP-associated proteins were transferred
to PVDF membranes. The membranes were prehybridized in
renaturation buffer (50 mM Tris–HCl pH 7.6, 50 mM NaCl,
1 mM EDTA, 1 mM DTT, 1% BSA) overnight at 4C and
incubated with in vitro transcribed 32P-labeled protamine RNA
(transcript c) (4) (105 c.p.m./ml) for 1 h at 23C in binding buffer
(10 mM Tris–HCl pH 7.6, 50 mM NaCl, 1 mM EDTA, 1 mM
DTT). The membrane was washed four times in binding buffer
for 20 min at 23C, dried, and exposed to X-ray film.
RESULTS
Identification and isolation of mouse paternal mRNPs
In order to identify and isolate proteins associated with mouse
testicular non-polysomal mRNAs, post-nuclear testicular extracts
were sedimented through a 20–60% Nycodenz gradient; a
gradient that resolves free proteins and polysomes from mRNPs
(25). To calibrate the gradient, RNA was purified from each
gradient fraction, electrophoresed in a 1% agarose formaldehyde
denaturing gel and stained with ethidium bromide. The position
of the polysomal RNA within the gradient was identified by the
electrophoretic mobilities of the 18S and 28S ribosomal RNAs
(Fig. 1a, fractions 11–15). The low molecular weight 4–5S RNAs
are seen in fractions 4 and 5.
To determine the location of non-polysomal mRNAs, purified
RNA aliquots were transferred to nitrocellulose for northern blot
analysis and probed with a 32P-labeled protamine 2 cDNA, a gene
known to be translationally repressed during spermiogenesis
(31). Most of the protamine 2 mRNA was detected in fractions
8–11 (Fig. 1b). These data indicate that mRNPs sediment in
fractions 8–11, between the 4–5S and ribosomal RNAs.
When protein content was assayed throughout the Nycodenz
gradient, the majority of protein was detected as free protein in
Figure 1. Calibration of Nycodenz gradient and identification and isolation of
mRNPs. Post-nuclear testicular extracts were sedimented on a 20–60%
Nycodenz gradient. The gradient was then divided into 18 fractions for several
analyses. (a) Deproteinized RNA was electrophoresed through a denaturing
formaldehyde–1% agarose gel and stained with ethidium bromide. (b) Northern
blot of the gel in the top panel probed with a 32P-labeled protamine 2 cDNA
(108 c.p.m./ml). (c) Protein content of each fraction as determined by Bradford
assay. (d) Western blot of protein electrophoresed through a 15% SDS–poly-
acylamide gel and detected with antibody to mRNP3+4.
fractions 3–7 (Fig. 1c). Western blot analysis of the Nycodenz
gradient fractions using an antibody which recognizes the mouse
homolog, MSY2 (24), revealed that MSY2 sedimented in
fractions 7–12, with a concentration in fractions 8–10. Since free
proteins sediment slowly in Nycodenz gradients, the more rapid
sedimentation of MSY2 suggests that MSY2 co-fractionates with
mRNAs (7,25,32). Based on the results presented in Figure 1,
fractions 8–10 were considered to contain an enriched population
of mRNPs and were pooled for further purification.
Characterization of mouse mRNP particles
The mRNP fraction (tubes 8–10), containing an enriched
population of proteins that bind to non-polysomal mRNAs, was
further purified from any co-sedimenting contaminating free
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Figure 2. Purification of mRNPs and identification of major masking proteins.
Following oligo(dT) selection, proteins were separated on a 10% SDS–PAGE
gel and monitored by (a) silver staining and (b) western blotting using
anti-mRNP3+4 antibody. Lane 1, aliquot (5 µg) of Nycodenz gradient fractions
8–10; lane 2, proteins (1 µg protein) associated with biotinylated oligo(dT)-bound
Streptavidin beads after washing; lane 3, proteins (0.1 µg protein) eluted from
oligo(dT) selected mRNPs.
proteins was monitored by silver staining (Fig. 2a) and by western
blotting (Fig. 2b) using antibody against mRNP3+4 which
recognizes the mouse homolog, MSY2 (24,26,27). Two major
proteins with estimated molecular weights of 52 and 70 kDa and
a number of minor proteins were found associated with the
oligo(dT) selected RNA (Fig. 1a, lane 3). When identical samples
were western-blotted using antibody against mRNP3+4, proteins
of 52 and 48 kDa were detected (Fig. 2b).
In order to identify the second major mRNP protein migrating
with an apparent molecular weight of 70 kDa, the protein was
purified from the gel and after an ingel tryptic digestion and
peptide separation by HPLC, a peptide of 12 amino acids was
sequenced. This sequence, EFSPFGTITSAK, was found to have
complete identity with an amino acid sequence in mouse
testicular poly(A) binding protein (PABP; amino acid positions
313–324; accession no. P29341) (33). We have previously
demonstrated that this 70 kDa PABP binds to both polysomal and
non-polysomal testicular mRNAs (34).
mRNPs reconstituted with an exogenous RNA show
translational repression ‘in vitro’
To investigate the ability of MSY2 and associated proteins to bind
and influence mRNA translation, mRNP proteins were dissociated
from RNA–protein complexes purified by oligo(dT) selection
and reconstituted with exogenous mRNAs such as luciferase
mRNA, which were then translated in vitro. Untreated, dissociated
and reconstituted mRNP particles were centrifuged through a
20–60% Nycodenz gradient, fractionated and assayed for MSY2
by western blotting. The control, i.e. untreated purified mRNP
particles, sedimented in fractions 7–10 (Fig. 3a). Dissociated
MSY2 was found predominantly in the free protein fractions 3–6
(Fig. 3b). When mRNPs were reconstituted using luciferase
RNA, the mRNP particles had identical sedimentation properties
to those of native untreated mRNP particles (Fig. 3c). Similar
results were obtained when brome mosaic viral RNA was used in
the reconstitution experiments, suggesting that MSY2 binds RNA in
vitro in a sequence-independent fashion (data not shown).
To determine whether the proteins dissociated from the
testicular mRNPs were able to inhibit the in vitro translation of
Figure 3. mRNPs reconstituted with an exogenous RNA and its subsequent
translational repression in vitro. Western blot using anti-mRNP3+4 antibody of
samples separated on a 20–60% Nycodenz gradient of (a) native mRNPs (4 µg
protein). (b) Dissociated mRNPs (4 µg protein) pre-treated with micrococcal
nuclease and Triton X-100. (c) mRNPs (4 µg protein) reconstituted with
luciferase mRNA (1 µg). (d) Cell-free translation of luciferase mRNA (1 µg)
pre-incubated in a solution of DOC, CaCl2, micrococcal nuclease, EGTA and
Triton X-100 at concentrations indicated in methods. –, free luciferase RNA;
+, reconstituted luciferase mRNPs. (e) Northern blot of total RNA after cell-free
translation (–) and total RNA purified from reconstituted mRNPs after cell-free
translation (+).
luciferase RNA upon reconstitution, reassembled particles were
translated in a rabbit reticulocyte lysate. Protein binding to
luciferase RNA resulted in the complete inhibition of its
translation (Fig. 3d). To rule out the possibility that RNA
degradation was the reason translation was abolished, an aliquot
of the post-translational mixture was phenol–chloroform extracted
twice and the RNA assayed by northern blotting with a
32P-labeled luciferase cDNA (Fig. 3e). No RNA degradation was
observed, suggesting that the translational repression resulted from
binding of the mRNP derived protein to the exogenous RNA.
MSY2 is phosphorylated in vivo and in vitro
CK2 co-isolates with Xenopus oocyte mRNP particles and is
believed to be responsible for the phosphorylation of mRNP3+4
within mRNP particles (15,18–20).
To test mouse testis mRNP particles for intrinsic protein kinase
activity, oligo(dT) selected mRNPs particles were incubated with
[γ-32P]ATP in kinase buffer. Radiolabeled MSY2 and a likely
degradation product of 33 kDa (24) were detected after immuno-
precipitation with anti-mRNP3+4 antibody (Fig. 4, lane 1), but not
after immunoprecipitation with control guinea pig serum (Fig. 4,
lane 2).
To determine whether MSY2 is also phosphorylated in vivo,
parallel studies were performed with enzymatically dispersed
mouse testicular cells incubated in [32P]orthophosphate (Fig. 4).
When the mRNP fractions (tubes 8–10) were immunoprecipitated
with anti-mRNP3+4 antibody, MSY2 was detected (Fig. 4,
lane 3). No radiolabeled protein was detected with control guinea
pig serum (Fig. 4, lane 4). These data demonstrate that MSY2 is
phosphorylated in vitro and in vivo and the kinase responsible for







niversity of Lincoln user on 13 Septem
ber 2018
1751
Nucleic Acids Research, 1994, Vol. 22, No. 1Nucleic Acids Research, 1999, Vol. 27, No. 7 1751
Figure 4. In vitro and in vivo phosphorylation of MSY2. Lane 1, in vitro
phosphorylated mRNPs (0.1 µg) immunoprecipitated with anti-mRNP3+4
antibody; lane 2, in vitro phosphorylated mRNPs (0.1 µg) incubated with
guinea pig serum; lane 3, in vivo phosphorylated mRNPs (0.1 µg) immuno-
precipitated with anti-mRNP3+4 antibody; lane 4, in vivo phosphorylated
mRNPs (0.1 µg) incubated with guinea pig serum. Proteins were separated by
SDS–PAGE and visualized by autoradiography.
Figure 5. MSY2 kinase is associated with MSY2 in a complex. Purified
oligo(dT) selected mRNPs (0.1 µg) were digested with RNase followed by
immunoprecipitation with anti-mRNP3+4 antibody or incubation with guinea
pig serum. The precipitated complexes were phosphorylated in vitro and the
products separated on 10% SDS–polyacrylamide gels. Lane 1, mRNPs incubated
with guinea pig serum; lane 2, mRNPs incubated with anti-mRNP3+4 antibody.
Proteins were separated by SDS–PAGE and visualized by autoradiography.
MSY2 kinase is associated with MSY2 in a complex 
To determine whether the immunoprecipitated kinase is physically
associated with MSY2 in a complex, oligo(dT) selected mRNPs
were digested with RNases A and T1, immunoprecipitated with
anti-mRNP3+4 antibody, and assayed for phosphorylation
(Fig. 5). One major phosphoprotein, MSY2, and the putative
33 kDa degradation product of MSY2 were detected (Fig. 5,
lane 2). No radiolabeled proteins were immunoprecipitated with
control guinea pig serum (Fig. 5, lane 1). These data indicate the
MSY2 kinase is associated with MSY2 within a protein complex.
The MSY2 associated kinase is not CK2
CK2 has been reported to phosphorylate mRNP3+4 in Xenopus
oocytes (15,18). To determine whether CK2 also functions in
mammalian testes to phosphorylate MSY2, in vitro kinase assays
were performed with testicular extracts in the presence of two
Figure 6. The MSY2 associated kinase is not CK2. (a) Control, phosphorylation
of casein (50 ng) by CK2 (5 U) in the presence of increasing amounts of heparin;
mRNPs, in vitro phosphorylation of mRNPs (0.1 µg per reaction) in the
presence of increasing amounts of heparin. (b) Control, phosphorylation of
casein (50 ng) by CK2 (5 U) in the presence of increasing amounts of DRB;
mRNPs, in vitro phosphorylation of mRNPs (0.1 µg per reaction) in the
presence of increasing amounts of DRB. Proteins were separated by
SDS–PAGE and visualized by autoradiography.
inhibitors of CK2: the general inhibitor, heparin (35), and a specific
CK2 inhibitor, 5,6-dichloro-1-β-D-ribofuranosylbenzimidazole
(DRB) (36). As a control, the ability of purified CK2 to
phosphorylate casein was also determined in the presence of these
inhibitors. At heparin concentrations of 10 µg/ml, the phosphory-
lation of casein by purified CK2 was completely inhibited
(Fig. 6a). However, heparin concentrations up to 100 µg/ml had
no effect on the phosphorylation of MSY2 by its associated kinase
(Fig. 6a). Since certain CK2 substrates such as nucleoplasmin are
resistant to inhibition by heparin (37), a more specific CK2
inhibitor, DRB, was employed (Fig. 6b). Although the phosphory-
lation of casein by purified CK2 was reduced dramatically by
2.4 µM DRB, the phosphorylation of MSY2 by its associated
kinase was unaffected at concentrations of DRB up to 24 µM
(Fig. 6b). These data suggest that the kinase we detect associated
with MSY2 differs from CK2.
Dephosphorylation of MSY2 results in decreased affinity
for RNA
Phosphorylation of mRNP3+4 has been reported to either increase
or not change its affinity to bind RNA (12,38). To determine
whether phosphorylation affects the binding of MSY2 to RNA,
oligo(dT) selected mRNPs were incubated with or without CIP,
separated by SDS–PAGE and analyzed by northwestern and
western blotting (Fig. 7). Northwestern blot analyses using
radiolabeled protamine mRNA as a probe revealed that dephos-
phorylation leads to a significant decrease in the affinity of two
mRNP proteins of 70 and 52 kDa to bind protamine mRNA
(Fig. 7i). The prominent protein band of ∼55 kDa seen after CIP
treatment is CIP. Western blot analysis using anti mRNP3+4
antibody of identical samples as seen in Figure 7i, run on the same
gel revealed that MSY2 migrated at the position of the 52 kDa
protein seen in Figure 7i (Fig. 7ii).
DISCUSSION
In this report we describe the isolation of mRNA–protein
particles from mouse male germ cells and the identification of the
major proteins associated with testicular non-polysomal mRNAs:
MSY2, the mammalian homolog to the Xenopus oocyte masking
protein, mRNP3+4, and a PABP (Fig. 2). We also detect a kinase
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Figure 7. Dephosphorylation of MSY2 results in a decrease in its affinity for
RNA. (i) Northwestern blot using 32P-labeled protamine 2 RNA (105 c.p.m./ml)
and (ii) western blot using anti mRNP3+4 antiserum of purified oligo(dT)
selected mRNPs (0.1 µg) pre-incubated in the presence (+) or absence (–) of
CIP (25 U/ml).
precipitates with MSY2 and can phosphorylate MSY2 in vitro
(Fig. 5). The MSY2 associated kinase appears not to be CK2, the
kinase believed to phosphorylate mRNP3+4 in oocytes (Fig. 6)
(15,18). Since dephosphorylation of MSY2 leads to a decrease in
its affinity to bind RNA (Fig. 7) and MSY2 is phosphorylated in
vivo (Fig. 4), mRNA masking in the testes may be regulated by
the phosphorylation states of MSY2. MSY2 can be dissociated
from its endogenous RNAs and reassociated with non-testicular
RNAs such as luciferase mRNA or brome mosaic virus RNA.
Association of the non-polysomal derived proteins to non-specific
mRNAs led to their translational repression in vitro (Fig. 3),
indicating that MSY2 binds RNA in a sequence-independent
fashion and its binding to mRNAs leads to their translational
repression.
MSY2 has recently been cloned and sequenced and was found
to be highly homologous to its Xenopus homolog (27). In the
mouse testis, MSY2 is believed to play a similar role in mRNA
masking as that of mRNP3+4 in Xenopus oocytes. In Xenopus
oocytes, both translationally competent and repressed RNAs are
packaged into mRNP particles; however, only specific RNAs are
recruited from these for translation (32). This suggests that
mRNP3+4 helps package a broad spectrum of RNAs. Additional
RNA binding proteins likely provide specificity of translational
repression and may regulate the recruitment of specific RNAs to
ribosomes (4,5).
In mammalian spermatogenesis many mRNAs are under
translational control and specific RNAs are temporally selected
for translation (4,5). Here we show that MSY2 can be dissociated
from its endogenous mRNAs and reassociated with non-testicular
mRNAs such as luciferase mRNA or brome mosaic virus mRNA.
Association of the non-polysomal-derived proteins to non-specific
mRNAs lead to their translational repression in vitro (Fig. 3), at
a protein to RNA mass ratio of ∼4:1. The translational repression
of luciferase mRNA following reconstitution with mRNP protein
may either be through the binding of MSY2 or MSY2 binding in
concert with other mRNP proteins (Fig. 3). Indeed, a number of
specific RNA-binding proteins, including TB-RBP (4) and Prbp
(5), bind to the 3′ untranslated region (UTR) of protamine and
other mRNAs and have been found associated with masked
paternal RNAs.
MSY1, an FRGY1 homolog, has also been shown to be
associated with mouse non-testicular RNAs (25). MSY1 appears
not to be one of the major mRNPs associated with non-polysomal
testicular RNAs, but is probably one of a number of less abundant
mRNA associated proteins (Fig. 2). As MSY2 is primarily
associated with non-polysomal mRNA, a major role for MSY2 in
vivo is probably to repress mRNA translation (Fig. 1). Therefore,
in this study we focus on the ability of MSY2 to inhibit translation
of mRNAs. Indeed, earlier work has shown that Y-box proteins
have the capacity to direct the translational repression of mRNA
in a rabbit reticulocyte lysate (11,39–42). This translational
repression is dependent on the protein to RNA mass ratio (40,41).
FRGY2, the homolog of MSY2, was shown to repress translation
of reconstituted mRNPs in vitro and in vivo (11,41). However, at
low protein to mRNA mass ratios (<2:1) a number of Y-box
proteins have been shown to enhance translation (39–41). This
enhancement may reflect the ability of mRNPs to destabilize
secondary structure within the 5′UTR which is inhibitory to
translational initiation (40). It is an intriguing possibility that
MSY2 may enhance translation at low MSY2 to mRNA ratios
and that Y-box proteins may play a dual role in translation. More
detailed studies using recombinant MSY2 will lead to a better
understanding of the role of MSY2 in translation.
MSY2 can bind RNA in an apparent sequence-independent
fashion as MSY2 binds to non-testicular mRNAs such as brome
mosaic virus mRNA and luciferase mRNA (Fig. 3). MSY2, like
FRGY2, may bind preferentially to specific sequences within the
mRNA (41,43). However, this selectability is not essential for the
translational repression of mRNAs by FRGY2, at least at high
FRGY2 to mRNA ratios (11–14,41).
PABP binds to the poly(A) tails of both mRNPs and polysomal
mRNAs in mouse testes (34). The highly conserved 70 kDa
PABP is an essential component in regulating poly(A)-dependent
events in translation initiation and mRNA turnover (44,45). In
mammalian cells, PABP helps protect RNAs from deadenylation/
degradation (46,47). Xenopus oocytes have low levels of PABP
which is believed to facilitate maturation-specific deadenylation
and translational inactivation of maternal mRNAs (48). The high
ratio of PABP to the major masking protein MSY2 (∼1:1)
reported here is in contrast to that ratio of PABP to mRNP3+4
associated with purified Xenopus oocyte mRNPs (19). Although
the functional significance of this is unclear, the high ratio of
PABP to MSY2 associated with paternal mRNAs may reflect the
relative lengths of the poly(A) tails of paternal and maternal
mRNAs. Most maternal mRNAs have relatively short poly(A)
tails of 15–80 nt (48,49) compared to the poly(A) tails of ∼160 nt
on many non-polysomal male germ cell mRNAs (31). PABP may
confer increased stability on the stored paternal mRNAs and/or
help in the masking process itself.
In addition to MSY2 and PABP, we have identified a kinase
activity associated with testicular non-polysomal mRNAs. This
kinase phosphorylates MSY2 in vitro. Dephosphorylation of
MSY2 leads to a decrease in its affinity to bind RNA, suggesting
the intriguing possibility that activation/inhibition of the MSY2
associated kinase and its phosphorylation of MSY2 may facilitate
masking and unmasking of translationally repressed paternal
mRNAs. However, we cannot exclude the possibility that another
kinase not associated with the mRNA particles phosphorylates
MSY2 in vivo.
mRNP3+4 is also phosphorylated in vivo and in vitro by a CK2
found associated with the mRNP particles of Xenopus oocytes
(18). In Xenopus oocytes, the role of phosphorylation in masking
has been examined by microinjection. Masking is blocked by
treating the oocytes with specific inhibitors of CK2 and by
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acts in vivo to promote the maturation of oocytes, coinciding with
the recruitment of various masked mRNAs for translation.
Progesterone-mediated unmasking is blocked by the specific
phosphatase inhibitor okadaic acid (15). This suggests that
phosphorylation of mRNP3+4 is required to maintain translational
repression. These masking and unmasking effects appear to be
independent of the mRNA polyadenylation status, as the addition
of cordycepin, which blocks polyadenylation, does not affect the
masking and unmasking of microinjected reporter mRNAs (15).
Although the proteins and mechanisms involved in masking
and unmasking of the germ cell stored mRNAs are probably highly
conserved among species, specific differences such as different
kinases appear to exist. Identification of the MSY2 associated
kinase, its transduction pathway and specific regulatory proteins
may help to define the mechanisms by which masking and
unmasking of paternal mRNAs are regulated in the mammalian
testis.
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